MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 196 filers reported holding MYRIAD GENETICS INC in Q4 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,494,000 | +7.3% | 130,705 | +2.2% | 0.39% | +10.9% |
| Q2 2022 | $2,325,000 | -28.7% | 127,949 | -1.1% | 0.35% | -14.3% |
| Q1 2022 | $3,262,000 | -10.5% | 129,435 | -2.0% | 0.41% | -12.5% |
| Q4 2021 | $3,646,000 | -16.5% | 132,101 | -2.3% | 0.46% | -15.9% |
| Q3 2021 | $4,368,000 | +32.6% | 135,267 | +25.6% | 0.55% | +33.0% |
| Q2 2021 | $3,293,000 | +109666.7% | 107,699 | +89649.2% | 0.42% | – |
| Q4 2018 | $3,000 | – | 120 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 6,459,139 | $278,776,000 | 5.53% |
| Tieton Capital Management, LLC | 119,290 | $5,149,000 | 4.04% |
| RPg Family Wealth Advisory, LLC | 97,202 | $4,195,238,000 | 3.85% |
| RK Capital | 384,900 | $16,612,000 | 2.90% |
| Contrarius Investment Management Ltd | 652,288 | $28,153,000 | 2.65% |
| S&T BANK/PA | 331,885 | $14,324,000 | 2.22% |
| Euclidean Technologies Management, LLC | 40,917 | $1,766,000 | 1.90% |
| AIMZ Investment Advisors, LLC | 45,635 | $1,970,000 | 1.80% |
| Taylor Frigon Capital Management LLC | 34,783 | $1,486,000 | 1.67% |
| KILLEN GROUP INC | 366,305 | $15,810,000 | 1.63% |